United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 415,200 | 444,700 | 446,500 | 379,100 | 384,900 |
| Cost of Goods | 34,600 | 27,700 | 37,200 | 23,000 | 34,800 |
| Gross Profit | 380,600 | 417,000 | 409,300 | 356,100 | 350,100 |
| Operating Expenses | 211,400 | 189,000 | 187,300 | 420,900 | 285,600 |
| Operating Income | 169,800 | 228,700 | 222,200 | -64,800 | 65,300 |
| Interest Expense | 4,700 | 4,600 | 4,700 | 4,600 | 4,800 |
| Other Income | -24,600 | -19,700 | -1,000 | 101,900 | 53,900 |
| Pre-tax Income | 140,500 | 204,400 | 216,500 | 32,500 | 114,400 |
| Income Tax | 28,300 | 41,700 | 43,900 | 4,200 | 15,600 |
| Net Income Continuous | 112,200 | 162,700 | 172,600 | 28,300 | 98,800 |
| Net Income | $112,200 | $162,700 | $172,600 | $28,300 | $98,800 |
| EPS Basic Total Ops | 2.50 | 3.62 | 3.85 | 0.63 | 2.22 |
| EPS Basic Continuous Ops | 2.49 | 3.62 | 3.85 | 0.63 | 2.23 |
| EPS Diluted Total Ops | 2.38 | 3.42 | 3.65 | 0.61 | 2.17 |
| EPS Diluted Continuous Ops | 2.38 | 3.42 | 3.65 | 0.61 | 2.17 |
| EBITDA(a) | $182,400 | $241,100 | $234,600 | $-52,300 | $78,400 |